

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.92396447 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.92396447 |
| 3 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.55254933 |
| 4 | fatty acid elongation (GO:0030497) | 3.54640759 |
| 5 | myelination (GO:0042552) | 3.44218349 |
| 6 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.42859441 |
| 7 | axon ensheathment (GO:0008366) | 3.41532309 |
| 8 | ensheathment of neurons (GO:0007272) | 3.41532309 |
| 9 | negative regulation of protein localization to cell surface (GO:2000009) | 3.37140912 |
| 10 | negative regulation of neurotransmitter transport (GO:0051589) | 3.35652480 |
| 11 | establishment of mitochondrion localization (GO:0051654) | 3.26595526 |
| 12 | postsynaptic membrane organization (GO:0001941) | 3.23429733 |
| 13 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.04389287 |
| 14 | paraxial mesoderm development (GO:0048339) | 3.00848026 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 2.95093974 |
| 16 | lymph vessel development (GO:0001945) | 2.91643735 |
| 17 | axonal fasciculation (GO:0007413) | 2.91515095 |
| 18 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.91225476 |
| 19 | neuron remodeling (GO:0016322) | 2.86771704 |
| 20 | eye photoreceptor cell differentiation (GO:0001754) | 2.84528260 |
| 21 | photoreceptor cell differentiation (GO:0046530) | 2.84528260 |
| 22 | neuron recognition (GO:0008038) | 2.81035523 |
| 23 | import into cell (GO:0098657) | 2.79504855 |
| 24 | limb bud formation (GO:0060174) | 2.78476055 |
| 25 | dendrite morphogenesis (GO:0048813) | 2.75833186 |
| 26 | presynaptic membrane organization (GO:0097090) | 2.71090576 |
| 27 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.70983242 |
| 28 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.70810688 |
| 29 | presynaptic membrane assembly (GO:0097105) | 2.70372051 |
| 30 | membrane assembly (GO:0071709) | 2.69764678 |
| 31 | lymphangiogenesis (GO:0001946) | 2.69329767 |
| 32 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.68018050 |
| 33 | apical protein localization (GO:0045176) | 2.62966877 |
| 34 | nerve growth factor signaling pathway (GO:0038180) | 2.61783622 |
| 35 | artery development (GO:0060840) | 2.60792469 |
| 36 | response to redox state (GO:0051775) | 2.57972282 |
| 37 | glomerular filtration (GO:0003094) | 2.55263398 |
| 38 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.55172342 |
| 39 | vocalization behavior (GO:0071625) | 2.51739154 |
| 40 | ganglion development (GO:0061548) | 2.49086584 |
| 41 | myelination in peripheral nervous system (GO:0022011) | 2.47982327 |
| 42 | peripheral nervous system axon ensheathment (GO:0032292) | 2.47982327 |
| 43 | negative regulation of axon guidance (GO:1902668) | 2.46965786 |
| 44 | asymmetric protein localization (GO:0008105) | 2.46530416 |
| 45 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.45696659 |
| 46 | lateral sprouting from an epithelium (GO:0060601) | 2.44819601 |
| 47 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.44572755 |
| 48 | hemidesmosome assembly (GO:0031581) | 2.43071987 |
| 49 | regulation of axon guidance (GO:1902667) | 2.41583093 |
| 50 | auditory behavior (GO:0031223) | 2.41123185 |
| 51 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.38870867 |
| 52 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.37197046 |
| 53 | Rap protein signal transduction (GO:0032486) | 2.35928431 |
| 54 | regulation of collateral sprouting (GO:0048670) | 2.34382817 |
| 55 | renal filtration (GO:0097205) | 2.33580427 |
| 56 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.32968729 |
| 57 | cholesterol biosynthetic process (GO:0006695) | 2.32656596 |
| 58 | myelin maintenance (GO:0043217) | 2.31877688 |
| 59 | adhesion of symbiont to host cell (GO:0044650) | 2.30242960 |
| 60 | virion attachment to host cell (GO:0019062) | 2.30242960 |
| 61 | notochord development (GO:0030903) | 2.29811483 |
| 62 | negative regulation of axonogenesis (GO:0050771) | 2.29725242 |
| 63 | dermatan sulfate biosynthetic process (GO:0030208) | 2.29007071 |
| 64 | regulation of pigment cell differentiation (GO:0050932) | 2.28969265 |
| 65 | positive regulation of synapse assembly (GO:0051965) | 2.26927265 |
| 66 | regulation of hippo signaling (GO:0035330) | 2.26895820 |
| 67 | neuron projection extension (GO:1990138) | 2.26841306 |
| 68 | response to lipoprotein particle (GO:0055094) | 2.26335963 |
| 69 | negative regulation of axon extension (GO:0030517) | 2.25372039 |
| 70 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.25091022 |
| 71 | glycerophospholipid catabolic process (GO:0046475) | 2.24499256 |
| 72 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.23984949 |
| 73 | embryonic foregut morphogenesis (GO:0048617) | 2.22978342 |
| 74 | endothelium development (GO:0003158) | 2.22877708 |
| 75 | retinal ganglion cell axon guidance (GO:0031290) | 2.22214944 |
| 76 | limb development (GO:0060173) | 2.21173893 |
| 77 | appendage development (GO:0048736) | 2.21173893 |
| 78 | cell migration in hindbrain (GO:0021535) | 2.19806083 |
| 79 | L-amino acid import (GO:0043092) | 2.19727437 |
| 80 | dendritic spine morphogenesis (GO:0060997) | 2.19547471 |
| 81 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.19303450 |
| 82 | synapse assembly (GO:0007416) | 2.19246295 |
| 83 | regulation of cell communication by electrical coupling (GO:0010649) | 2.18072302 |
| 84 | response to methylmercury (GO:0051597) | 2.16295772 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.16268607 |
| 86 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.15053769 |
| 87 | extracellular matrix assembly (GO:0085029) | 2.14376959 |
| 88 | ephrin receptor signaling pathway (GO:0048013) | 2.13442355 |
| 89 | chondrocyte proliferation (GO:0035988) | 2.12738131 |
| 90 | regulation of synapse assembly (GO:0051963) | 2.12565958 |
| 91 | axon extension (GO:0048675) | 2.11829659 |
| 92 | glomerular basement membrane development (GO:0032836) | 2.11457374 |
| 93 | astrocyte development (GO:0014002) | 2.11429738 |
| 94 | hippo signaling (GO:0035329) | 2.11061116 |
| 95 | synaptic vesicle maturation (GO:0016188) | 2.10331629 |
| 96 | neurofilament cytoskeleton organization (GO:0060052) | 2.09610711 |
| 97 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.09329931 |
| 98 | axon extension involved in axon guidance (GO:0048846) | 2.09329931 |
| 99 | sterol biosynthetic process (GO:0016126) | 2.09188180 |
| 100 | neuronal action potential propagation (GO:0019227) | 2.08640731 |
| 101 | peripheral nervous system development (GO:0007422) | 2.08405207 |
| 102 | protein localization to endosome (GO:0036010) | 2.08341830 |
| 103 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.08248686 |
| 104 | negative chemotaxis (GO:0050919) | 2.06828185 |
| 105 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.06523227 |
| 106 | mitochondrion transport along microtubule (GO:0047497) | 2.06523227 |
| 107 | dermatan sulfate metabolic process (GO:0030205) | 2.06482148 |
| 108 | endothelial cell morphogenesis (GO:0001886) | 2.06427006 |
| 109 | negative regulation of cartilage development (GO:0061037) | 2.06270481 |
| 110 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.05799310 |
| 111 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.04497445 |
| 112 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.04360466 |
| 113 | positive regulation of vasculogenesis (GO:2001214) | 2.03846435 |
| 114 | camera-type eye morphogenesis (GO:0048593) | 2.03781036 |
| 115 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.03675281 |
| 116 | substantia nigra development (GO:0021762) | 2.03296183 |
| 117 | generation of neurons (GO:0048699) | 2.02853394 |
| 118 | isoprenoid biosynthetic process (GO:0008299) | 2.02590596 |
| 119 | transmission of nerve impulse (GO:0019226) | 2.02253156 |
| 120 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.02031940 |
| 121 | myelin assembly (GO:0032288) | 2.01199229 |
| 122 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.00916681 |
| 123 | smooth muscle tissue development (GO:0048745) | 2.00783722 |
| 124 | positive regulation of action potential (GO:0045760) | 2.00017797 |
| 125 | clathrin coat assembly (GO:0048268) | 1.99685254 |
| 126 | nucleobase catabolic process (GO:0046113) | 1.99389157 |
| 127 | regulation of transforming growth factor beta2 production (GO:0032909) | 1.98573135 |
| 128 | protein heterotrimerization (GO:0070208) | 1.98539755 |
| 129 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.98283650 |
| 130 | developmental induction (GO:0031128) | 1.98013405 |
| 131 | cell adhesion mediated by integrin (GO:0033627) | 1.97712168 |
| 132 | neuronal ion channel clustering (GO:0045161) | 1.97701312 |
| 133 | Golgi to plasma membrane protein transport (GO:0043001) | 1.97624789 |
| 134 | mechanosensory behavior (GO:0007638) | 1.97619156 |
| 135 | protein localization to synapse (GO:0035418) | 1.97520713 |
| 136 | protein targeting to plasma membrane (GO:0072661) | 1.97183584 |
| 137 | cellular response to monoamine stimulus (GO:0071868) | 1.95880477 |
| 138 | cellular response to catecholamine stimulus (GO:0071870) | 1.95880477 |
| 139 | response to catecholamine (GO:0071869) | 1.95316697 |
| 140 | response to monoamine (GO:0071867) | 1.95316697 |
| 141 | central nervous system neuron axonogenesis (GO:0021955) | 1.95270136 |
| 142 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 1.95104899 |
| 143 | cellular response to epinephrine stimulus (GO:0071872) | 1.94834982 |
| 144 | lung-associated mesenchyme development (GO:0060484) | 1.94804436 |
| 145 | cerebral cortex cell migration (GO:0021795) | 1.94398589 |
| 146 | dendrite development (GO:0016358) | 1.93675457 |
| 147 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 1.93500985 |
| 148 | organ induction (GO:0001759) | 1.93156522 |
| 149 | gamma-aminobutyric acid transport (GO:0015812) | 1.92872295 |
| 150 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 1.92258802 |
| 151 | nonmotile primary cilium assembly (GO:0035058) | 1.91920949 |
| 152 | synapse organization (GO:0050808) | 1.91514976 |
| 153 | collagen fibril organization (GO:0030199) | 1.91026450 |
| 154 | response to auditory stimulus (GO:0010996) | 1.89203529 |
| 155 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.88707086 |
| 156 | mesenchymal-epithelial cell signaling (GO:0060638) | 1.88352985 |
| 157 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 1.88297117 |
| 158 | branching involved in salivary gland morphogenesis (GO:0060445) | 1.88193153 |
| 159 | layer formation in cerebral cortex (GO:0021819) | 1.88190174 |
| 160 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 1.86172334 |
| 161 | establishment of tissue polarity (GO:0007164) | 1.85838795 |
| 162 | establishment of planar polarity (GO:0001736) | 1.85838795 |
| 163 | spinal cord development (GO:0021510) | 1.85369236 |
| 164 | anterior/posterior axis specification, embryo (GO:0008595) | 1.84947532 |
| 165 | negative regulation of keratinocyte proliferation (GO:0010839) | 1.83669338 |
| 166 | C4-dicarboxylate transport (GO:0015740) | 1.83000287 |
| 167 | developmental cell growth (GO:0048588) | 1.82818060 |
| 168 | dorsal/ventral axis specification (GO:0009950) | 1.81907552 |
| 169 | establishment of nucleus localization (GO:0040023) | 1.81154328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44694945 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.73152001 |
| 3 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.35482990 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.30656961 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.28541779 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.18078514 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12073383 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11814227 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05951170 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05951170 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.04618145 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.04175967 |
| 13 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.02394818 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.02195593 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01040286 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99975037 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.98269740 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95159946 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93650244 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89531615 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88071695 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86712193 |
| 23 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.83569626 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83521220 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82125243 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80922089 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80595177 |
| 28 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78265291 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.77724837 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76531749 |
| 31 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.74958577 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.74675469 |
| 33 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72094502 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.68574724 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64579565 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.64534929 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63826592 |
| 38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61505753 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61219990 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58812273 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.57638778 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.57530310 |
| 43 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.56785397 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.56785397 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54566904 |
| 46 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53613368 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52597471 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52265254 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51810552 |
| 50 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50049348 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48597446 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47210154 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45911449 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45844470 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45034568 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41909494 |
| 57 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41280298 |
| 58 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38303342 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36673905 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34126487 |
| 61 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.33221989 |
| 62 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.33137133 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.32481371 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32292673 |
| 65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31266688 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30578668 |
| 67 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29901189 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29542676 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28086205 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27979442 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27724457 |
| 72 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25906884 |
| 73 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.24117938 |
| 74 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23301010 |
| 75 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22580078 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21192629 |
| 77 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19451627 |
| 78 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19259174 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18537076 |
| 80 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.18068642 |
| 81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16963132 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15815836 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15726334 |
| 84 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.14074210 |
| 85 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13603765 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13214900 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13042664 |
| 88 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11033227 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10637092 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09455744 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09119573 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08666334 |
| 93 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08157571 |
| 94 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07613163 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06671741 |
| 96 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.06350080 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06195529 |
| 98 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.05873605 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05796280 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05544652 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04572339 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04389355 |
| 103 | JUN_21703547_ChIP-Seq_K562_Human | 1.04273893 |
| 104 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04248529 |
| 105 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02271400 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02056596 |
| 107 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.01926613 |
| 108 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01774739 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00379602 |
| 110 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00229282 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99389697 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99376113 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98411503 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98215591 |
| 115 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97329193 |
| 116 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96397765 |
| 117 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96060062 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95861999 |
| 119 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95452453 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94866674 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92742630 |
| 122 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91595520 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91196558 |
| 124 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91044150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 2.99232386 |
| 2 | MP0004270_analgesia | 2.89792403 |
| 3 | MP0003950_abnormal_plasma_membrane | 2.74770854 |
| 4 | MP0000920_abnormal_myelination | 2.66442454 |
| 5 | MP0004272_abnormal_basement_membrane | 2.66044900 |
| 6 | MP0005623_abnormal_meninges_morphology | 2.57227964 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.50259428 |
| 8 | MP0003880_abnormal_central_pattern | 2.49390270 |
| 9 | MP0010030_abnormal_orbit_morphology | 2.30389767 |
| 10 | MP0001879_abnormal_lymphatic_vessel | 2.28367449 |
| 11 | MP0000778_abnormal_nervous_system | 2.26581836 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.25616494 |
| 13 | MP0003941_abnormal_skin_development | 2.00868059 |
| 14 | MP0010368_abnormal_lymphatic_system | 1.91969573 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 1.87646526 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 1.75201858 |
| 17 | MP0005409_darkened_coat_color | 1.72547308 |
| 18 | MP0001299_abnormal_eye_distance/ | 1.70895033 |
| 19 | MP0001486_abnormal_startle_reflex | 1.65146453 |
| 20 | MP0001188_hyperpigmentation | 1.63469370 |
| 21 | MP0002272_abnormal_nervous_system | 1.59201337 |
| 22 | MP0000751_myopathy | 1.58699866 |
| 23 | MP0003634_abnormal_glial_cell | 1.57768291 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.55994731 |
| 25 | MP0002295_abnormal_pulmonary_circulatio | 1.55738038 |
| 26 | MP0003690_abnormal_glial_cell | 1.52773893 |
| 27 | MP0004742_abnormal_vestibular_system | 1.52208339 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.50150881 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.46839135 |
| 30 | MP0002064_seizures | 1.43535976 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.41943031 |
| 32 | MP0001905_abnormal_dopamine_level | 1.40952853 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.39971900 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.38954410 |
| 35 | MP0004134_abnormal_chest_morphology | 1.38066137 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.37601451 |
| 37 | MP0009384_cardiac_valve_regurgitation | 1.34294624 |
| 38 | MP0003136_yellow_coat_color | 1.33847685 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.33468186 |
| 40 | MP0005248_abnormal_Harderian_gland | 1.33160970 |
| 41 | MP0009046_muscle_twitch | 1.32836518 |
| 42 | MP0000762_abnormal_tongue_morphology | 1.30599145 |
| 43 | MP0000534_abnormal_ureter_morphology | 1.30036475 |
| 44 | MP0000049_abnormal_middle_ear | 1.29242231 |
| 45 | MP0001958_emphysema | 1.28895997 |
| 46 | MP0002108_abnormal_muscle_morphology | 1.27991256 |
| 47 | MP0003385_abnormal_body_wall | 1.26896040 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.26731676 |
| 49 | MP0001984_abnormal_olfaction | 1.26036469 |
| 50 | MP0004133_heterotaxia | 1.24559130 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.24078011 |
| 52 | MP0000749_muscle_degeneration | 1.22407567 |
| 53 | MP0009250_abnormal_appendicular_skeleto | 1.21417590 |
| 54 | MP0004484_altered_response_of | 1.21058873 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.20087975 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.19943592 |
| 57 | MP0005187_abnormal_penis_morphology | 1.19551063 |
| 58 | MP0003279_aneurysm | 1.19184411 |
| 59 | MP0002234_abnormal_pharynx_morphology | 1.17329524 |
| 60 | MP0004858_abnormal_nervous_system | 1.17215899 |
| 61 | MP0001529_abnormal_vocalization | 1.15935370 |
| 62 | MP0009745_abnormal_behavioral_response | 1.15650222 |
| 63 | MP0004885_abnormal_endolymph | 1.15037159 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.14807294 |
| 65 | MP0002184_abnormal_innervation | 1.14413689 |
| 66 | MP0002697_abnormal_eye_size | 1.14258233 |
| 67 | MP0003942_abnormal_urinary_system | 1.14149716 |
| 68 | MP0001177_atelectasis | 1.13626988 |
| 69 | MP0002233_abnormal_nose_morphology | 1.13356813 |
| 70 | MP0003091_abnormal_cell_migration | 1.11834943 |
| 71 | MP0003122_maternal_imprinting | 1.10573952 |
| 72 | MP0000428_abnormal_craniofacial_morphol | 1.09721996 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.08846303 |
| 74 | MP0003119_abnormal_digestive_system | 1.08781739 |
| 75 | MP0001293_anophthalmia | 1.08311985 |
| 76 | MP0000579_abnormal_nail_morphology | 1.08100776 |
| 77 | MP0000383_abnormal_hair_follicle | 1.06702276 |
| 78 | MP0004036_abnormal_muscle_relaxation | 1.04817413 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.04275233 |
| 80 | MP0001970_abnormal_pain_threshold | 1.04272021 |
| 81 | MP0004085_abnormal_heartbeat | 1.03868123 |
| 82 | MP0000647_abnormal_sebaceous_gland | 1.03609653 |
| 83 | MP0001485_abnormal_pinna_reflex | 1.03580890 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.02138333 |
| 85 | MP0003632_abnormal_nervous_system | 1.01505113 |
| 86 | MP0000955_abnormal_spinal_cord | 1.00832496 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.98797200 |
| 88 | MP0003631_nervous_system_phenotype | 0.97618961 |
| 89 | MP0008789_abnormal_olfactory_epithelium | 0.97498779 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.97378353 |
| 91 | MP0009053_abnormal_anal_canal | 0.97109557 |
| 92 | MP0004142_abnormal_muscle_tone | 0.96521778 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.96498413 |
| 94 | MP0005508_abnormal_skeleton_morphology | 0.96211752 |
| 95 | MP0002133_abnormal_respiratory_system | 0.95503294 |
| 96 | MP0005388_respiratory_system_phenotype | 0.95503294 |
| 97 | MP0003935_abnormal_craniofacial_develop | 0.94989848 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.94488978 |
| 99 | MP0003633_abnormal_nervous_system | 0.93652308 |
| 100 | MP0003828_pulmonary_edema | 0.93447377 |
| 101 | MP0001968_abnormal_touch/_nociception | 0.93232659 |
| 102 | MP0004084_abnormal_cardiac_muscle | 0.92463139 |
| 103 | MP0003937_abnormal_limbs/digits/tail_de | 0.92298899 |
| 104 | MP0004924_abnormal_behavior | 0.92064835 |
| 105 | MP0005386_behavior/neurological_phenoty | 0.92064835 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.91576958 |
| 107 | MP0002736_abnormal_nociception_after | 0.90798774 |
| 108 | MP0003861_abnormal_nervous_system | 0.90638950 |
| 109 | MP0002229_neurodegeneration | 0.90637056 |
| 110 | MP0003755_abnormal_palate_morphology | 0.90625885 |
| 111 | MP0002752_abnormal_somatic_nervous | 0.88943516 |
| 112 | MP0003724_increased_susceptibility_to | 0.88770445 |
| 113 | MP0002733_abnormal_thermal_nociception | 0.88403788 |
| 114 | MP0002092_abnormal_eye_morphology | 0.87859431 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.87725224 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.87062706 |
| 117 | MP0000026_abnormal_inner_ear | 0.86825488 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.86098928 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.85905985 |
| 120 | MP0002938_white_spotting | 0.85824568 |
| 121 | MP0005164_abnormal_response_to | 0.85708663 |
| 122 | MP0004883_abnormal_blood_vessel | 0.85656468 |
| 123 | MP0001286_abnormal_eye_development | 0.85434367 |
| 124 | MP0003329_amyloid_beta_deposits | 0.85225781 |
| 125 | MP0003045_fibrosis | 0.84706241 |
| 126 | MP0000462_abnormal_digestive_system | 0.84649448 |
| 127 | MP0006138_congestive_heart_failure | 0.84310864 |
| 128 | MP0005394_taste/olfaction_phenotype | 0.83539547 |
| 129 | MP0005499_abnormal_olfactory_system | 0.83539547 |
| 130 | MP0005195_abnormal_posterior_eye | 0.83224146 |
| 131 | MP0000767_abnormal_smooth_muscle | 0.82923129 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.82825679 |
| 133 | MP0002282_abnormal_trachea_morphology | 0.82432172 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.81135032 |
| 135 | MP0009379_abnormal_foot_pigmentation | 0.80541058 |
| 136 | MP0002066_abnormal_motor_capabilities/c | 0.80308011 |
| 137 | MP0000013_abnormal_adipose_tissue | 0.80163907 |
| 138 | MP0005275_abnormal_skin_tensile | 0.80018352 |
| 139 | MP0000566_synostosis | 0.79572681 |
| 140 | MP0002152_abnormal_brain_morphology | 0.79542773 |
| 141 | MP0005369_muscle_phenotype | 0.79541478 |
| 142 | MP0006072_abnormal_retinal_apoptosis | 0.79359854 |
| 143 | MP0005391_vision/eye_phenotype | 0.79286900 |
| 144 | MP0010678_abnormal_skin_adnexa | 0.78883638 |
| 145 | MP0000432_abnormal_head_morphology | 0.78410382 |
| 146 | MP0000427_abnormal_hair_cycle | 0.77324268 |
| 147 | MP0000631_abnormal_neuroendocrine_gland | 0.76352796 |
| 148 | MP0005646_abnormal_pituitary_gland | 0.75989363 |
| 149 | MP0002557_abnormal_social/conspecific_i | 0.75277913 |
| 150 | MP0000467_abnormal_esophagus_morphology | 0.75005155 |
| 151 | MP0002932_abnormal_joint_morphology | 0.74327303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.59281838 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.59281838 |
| 3 | Abnormality of the corticospinal tract (HP:0002492) | 3.51262191 |
| 4 | Termporal pattern (HP:0011008) | 3.33943042 |
| 5 | Insidious onset (HP:0003587) | 3.33943042 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.14842703 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.04712203 |
| 8 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.74726508 |
| 9 | Aplasia of the phalanges of the hand (HP:0009802) | 2.74726508 |
| 10 | Aplasia involving bones of the extremities (HP:0009825) | 2.74726508 |
| 11 | Onion bulb formation (HP:0003383) | 2.73910802 |
| 12 | Retinal dysplasia (HP:0007973) | 2.65634995 |
| 13 | Sensory axonal neuropathy (HP:0003390) | 2.60301398 |
| 14 | Muscle fiber splitting (HP:0003555) | 2.54536573 |
| 15 | Scanning speech (HP:0002168) | 2.52770116 |
| 16 | Parakeratosis (HP:0001036) | 2.52543372 |
| 17 | Hypoplasia of the iris (HP:0007676) | 2.52308329 |
| 18 | Action tremor (HP:0002345) | 2.42033390 |
| 19 | Abnormality of dentin (HP:0010299) | 2.41608515 |
| 20 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.41331309 |
| 21 | Protrusio acetabuli (HP:0003179) | 2.35364202 |
| 22 | Lower limb muscle weakness (HP:0007340) | 2.32800523 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 2.32784202 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 2.31223906 |
| 25 | Atonic seizures (HP:0010819) | 2.29813274 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.28542366 |
| 27 | Ulnar claw (HP:0001178) | 2.27496977 |
| 28 | Cutaneous finger syndactyly (HP:0010554) | 2.26710743 |
| 29 | Buphthalmos (HP:0000557) | 2.25841625 |
| 30 | Ankle clonus (HP:0011448) | 2.22436937 |
| 31 | Aortic dissection (HP:0002647) | 2.22423946 |
| 32 | Coronal craniosynostosis (HP:0004440) | 2.17972307 |
| 33 | Pheochromocytoma (HP:0002666) | 2.16427808 |
| 34 | Submucous cleft hard palate (HP:0000176) | 2.16368597 |
| 35 | Arterial tortuosity (HP:0005116) | 2.15235598 |
| 36 | Infantile muscular hypotonia (HP:0008947) | 2.14757637 |
| 37 | Hypoplastic ischia (HP:0003175) | 2.13431117 |
| 38 | Foot dorsiflexor weakness (HP:0009027) | 2.12284773 |
| 39 | Steppage gait (HP:0003376) | 2.07993841 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.07962533 |
| 41 | Morphological abnormality of the middle ear (HP:0008609) | 2.07905377 |
| 42 | Bradycardia (HP:0001662) | 2.05454371 |
| 43 | Myokymia (HP:0002411) | 2.02196585 |
| 44 | Abnormality of the ischium (HP:0003174) | 2.02118017 |
| 45 | Broad metatarsal (HP:0001783) | 2.01660449 |
| 46 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.01591615 |
| 47 | Wrist flexion contracture (HP:0001239) | 2.01024813 |
| 48 | Soft skin (HP:0000977) | 1.99573181 |
| 49 | Lower limb amyotrophy (HP:0007210) | 1.99128312 |
| 50 | Decreased motor nerve conduction velocity (HP:0003431) | 1.97969115 |
| 51 | Dysmetria (HP:0001310) | 1.97505621 |
| 52 | Overgrowth (HP:0001548) | 1.96584780 |
| 53 | Bell-shaped thorax (HP:0001591) | 1.96307478 |
| 54 | Cutaneous syndactyly (HP:0012725) | 1.96173864 |
| 55 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96063368 |
| 56 | Prolonged QT interval (HP:0001657) | 1.94719734 |
| 57 | Abnormality of the foot musculature (HP:0001436) | 1.92806832 |
| 58 | Thickened helices (HP:0000391) | 1.91365907 |
| 59 | Limb dystonia (HP:0002451) | 1.90372524 |
| 60 | Fibular aplasia (HP:0002990) | 1.90144438 |
| 61 | Microglossia (HP:0000171) | 1.88327020 |
| 62 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.88322062 |
| 63 | Spastic gait (HP:0002064) | 1.87285139 |
| 64 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.87082879 |
| 65 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.86399866 |
| 66 | Genital tract atresia (HP:0001827) | 1.85113570 |
| 67 | Vascular tortuosity (HP:0004948) | 1.85032071 |
| 68 | Hyperventilation (HP:0002883) | 1.84804111 |
| 69 | Abnormality of incisor morphology (HP:0011063) | 1.84139580 |
| 70 | Spinal rigidity (HP:0003306) | 1.83666184 |
| 71 | Adrenal hypoplasia (HP:0000835) | 1.83569470 |
| 72 | Alacrima (HP:0000522) | 1.83563436 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 1.83523019 |
| 74 | Focal seizures (HP:0007359) | 1.83225059 |
| 75 | Abnormal auditory evoked potentials (HP:0006958) | 1.81597778 |
| 76 | Bronchomalacia (HP:0002780) | 1.81578507 |
| 77 | Limited hip movement (HP:0008800) | 1.81324620 |
| 78 | Abnormality of the calf musculature (HP:0001430) | 1.80157398 |
| 79 | Vaginal atresia (HP:0000148) | 1.77853319 |
| 80 | Bladder diverticulum (HP:0000015) | 1.77535155 |
| 81 | Pulmonary artery stenosis (HP:0004415) | 1.77485201 |
| 82 | Gait imbalance (HP:0002141) | 1.77380267 |
| 83 | Abnormality of the nasal septum (HP:0000419) | 1.77162554 |
| 84 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.76844370 |
| 85 | Slow saccadic eye movements (HP:0000514) | 1.76417561 |
| 86 | Short 4th metacarpal (HP:0010044) | 1.75917143 |
| 87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.75917143 |
| 88 | Pterygium (HP:0001059) | 1.74816099 |
| 89 | Focal motor seizures (HP:0011153) | 1.74600522 |
| 90 | Aqueductal stenosis (HP:0002410) | 1.73687415 |
| 91 | Neuroendocrine neoplasm (HP:0100634) | 1.73229203 |
| 92 | Megalencephaly (HP:0001355) | 1.72738958 |
| 93 | Cortical dysplasia (HP:0002539) | 1.71863888 |
| 94 | Peripheral hypomyelination (HP:0007182) | 1.71606177 |
| 95 | Corneal dystrophy (HP:0001131) | 1.71581323 |
| 96 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.70392172 |
| 97 | Stridor (HP:0010307) | 1.70275491 |
| 98 | Aortic aneurysm (HP:0004942) | 1.69170707 |
| 99 | Calf muscle hypertrophy (HP:0008981) | 1.68845713 |
| 100 | Atrophic scars (HP:0001075) | 1.68818533 |
| 101 | Chin dimple (HP:0010751) | 1.68545844 |
| 102 | Autoamputation (HP:0001218) | 1.68491696 |
| 103 | Hypothermia (HP:0002045) | 1.66988404 |
| 104 | Distal lower limb amyotrophy (HP:0008944) | 1.66931189 |
| 105 | Wormian bones (HP:0002645) | 1.66403749 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66041122 |
| 107 | Increased corneal curvature (HP:0100692) | 1.65687308 |
| 108 | Keratoconus (HP:0000563) | 1.65687308 |
| 109 | Difficulty running (HP:0009046) | 1.65503469 |
| 110 | Epileptic encephalopathy (HP:0200134) | 1.65446855 |
| 111 | Atrial fibrillation (HP:0005110) | 1.65164224 |
| 112 | Hemiparesis (HP:0001269) | 1.64948255 |
| 113 | Vertebral arch anomaly (HP:0008438) | 1.64723842 |
| 114 | Shallow orbits (HP:0000586) | 1.64620861 |
| 115 | Anteriorly placed anus (HP:0001545) | 1.64376358 |
| 116 | Bifid tongue (HP:0010297) | 1.64190405 |
| 117 | Neonatal short-limb short stature (HP:0008921) | 1.64113968 |
| 118 | Gowers sign (HP:0003391) | 1.64066679 |
| 119 | EMG: myopathic abnormalities (HP:0003458) | 1.63975907 |
| 120 | Febrile seizures (HP:0002373) | 1.63960314 |
| 121 | Specific learning disability (HP:0001328) | 1.63602473 |
| 122 | Hepatoblastoma (HP:0002884) | 1.63420173 |
| 123 | Choroideremia (HP:0001139) | 1.62435764 |
| 124 | Medial flaring of the eyebrow (HP:0010747) | 1.61742248 |
| 125 | Preaxial foot polydactyly (HP:0001841) | 1.60381951 |
| 126 | Myelomeningocele (HP:0002475) | 1.59646212 |
| 127 | Absent frontal sinuses (HP:0002688) | 1.57424758 |
| 128 | Anterior segment dysgenesis (HP:0007700) | 1.56956554 |
| 129 | Wide anterior fontanel (HP:0000260) | 1.56329452 |
| 130 | Drooling (HP:0002307) | 1.54079812 |
| 131 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.53260013 |
| 132 | Vertebral clefting (HP:0008428) | 1.53050767 |
| 133 | Bowel diverticulosis (HP:0005222) | 1.52151769 |
| 134 | Abnormality of the astrocytes (HP:0100707) | 1.52101339 |
| 135 | Astrocytoma (HP:0009592) | 1.52101339 |
| 136 | Colon cancer (HP:0003003) | 1.51149588 |
| 137 | Papillary thyroid carcinoma (HP:0002895) | 1.50832402 |
| 138 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.49772220 |
| 139 | Glioma (HP:0009733) | 1.49475990 |
| 140 | Pulmonic stenosis (HP:0001642) | 1.49325025 |
| 141 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.49050179 |
| 142 | Ankle contracture (HP:0006466) | 1.48675607 |
| 143 | Myotonia (HP:0002486) | 1.48073524 |
| 144 | Short tibia (HP:0005736) | 1.46031910 |
| 145 | Turricephaly (HP:0000262) | 1.44724420 |
| 146 | Esophageal atresia (HP:0002032) | 1.43349918 |
| 147 | Optic nerve hypoplasia (HP:0000609) | 1.43030176 |
| 148 | Chorioretinal atrophy (HP:0000533) | 1.42892597 |
| 149 | Congenital primary aphakia (HP:0007707) | 1.42599250 |
| 150 | Fibular hypoplasia (HP:0003038) | 1.42016984 |
| 151 | Renal hypoplasia (HP:0000089) | 1.41985959 |
| 152 | Abnormality of the diencephalon (HP:0010662) | 1.40521668 |
| 153 | Genetic anticipation (HP:0003743) | 1.39716636 |
| 154 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.38444581 |
| 155 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.37188783 |
| 156 | Septo-optic dysplasia (HP:0100842) | 1.36895904 |
| 157 | Neoplasm of the oral cavity (HP:0100649) | 1.35565098 |
| 158 | Abnormality of the anterior chamber (HP:0000593) | 1.34419147 |
| 159 | Synostosis of carpal bones (HP:0005048) | 1.34114193 |
| 160 | Renal dysplasia (HP:0000110) | 1.34082521 |
| 161 | Cerebellar dysplasia (HP:0007033) | 1.33600673 |
| 162 | Anophthalmia (HP:0000528) | 1.32935227 |
| 163 | Aortic valve stenosis (HP:0001650) | 1.32660435 |
| 164 | Short nail (HP:0001799) | 1.31475093 |
| 165 | Fragile skin (HP:0001030) | 1.31342959 |
| 166 | Stenosis of the external auditory canal (HP:0000402) | 1.31170108 |
| 167 | Nephrogenic diabetes insipidus (HP:0009806) | 1.29513091 |
| 168 | Split foot (HP:0001839) | 1.28606606 |
| 169 | Short hallux (HP:0010109) | 1.26855757 |
| 170 | Midline defect of the nose (HP:0004122) | 1.26597061 |
| 171 | Tracheal stenosis (HP:0002777) | 1.26482157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.97954899 |
| 2 | BCR | 2.71087713 |
| 3 | OXSR1 | 2.67928731 |
| 4 | CASK | 2.64269957 |
| 5 | TIE1 | 2.43299491 |
| 6 | EPHB1 | 2.01592350 |
| 7 | MARK1 | 1.99730682 |
| 8 | PRPF4B | 1.86312575 |
| 9 | MAPKAPK5 | 1.86280844 |
| 10 | MAPK13 | 1.83607196 |
| 11 | WNK1 | 1.80577813 |
| 12 | WNK4 | 1.80266097 |
| 13 | BMPR1B | 1.75827093 |
| 14 | PDGFRA | 1.75525601 |
| 15 | PKN1 | 1.75167130 |
| 16 | SGK223 | 1.71850010 |
| 17 | SGK494 | 1.71850010 |
| 18 | LIMK1 | 1.59288700 |
| 19 | STK38L | 1.52443633 |
| 20 | AKT3 | 1.50488090 |
| 21 | NTRK3 | 1.42858367 |
| 22 | PNCK | 1.41465932 |
| 23 | PLK2 | 1.38852655 |
| 24 | TSSK6 | 1.35995765 |
| 25 | PBK | 1.35885150 |
| 26 | FGFR2 | 1.35678560 |
| 27 | EPHB2 | 1.32427170 |
| 28 | DDR2 | 1.30867717 |
| 29 | CSNK1A1L | 1.30303388 |
| 30 | MET | 1.29064891 |
| 31 | NEK6 | 1.27365924 |
| 32 | DYRK2 | 1.27359795 |
| 33 | PINK1 | 1.25835026 |
| 34 | PTK2B | 1.25160556 |
| 35 | PAK3 | 1.23897045 |
| 36 | DMPK | 1.23728063 |
| 37 | FER | 1.18996628 |
| 38 | UHMK1 | 1.17648356 |
| 39 | PRKCE | 1.15939743 |
| 40 | PHKG2 | 1.15362959 |
| 41 | PHKG1 | 1.15362959 |
| 42 | ERBB3 | 1.14049538 |
| 43 | MINK1 | 1.09597925 |
| 44 | CAMK2B | 1.08425837 |
| 45 | NTRK1 | 1.07220429 |
| 46 | CAMK2D | 1.06832740 |
| 47 | NEK9 | 1.05808142 |
| 48 | PIK3CA | 1.05734173 |
| 49 | KDR | 1.02878826 |
| 50 | ROCK2 | 1.02791392 |
| 51 | INSRR | 1.02437956 |
| 52 | FRK | 1.02348946 |
| 53 | TNIK | 0.99929849 |
| 54 | MAP4K2 | 0.99851560 |
| 55 | CSNK1G2 | 0.99589192 |
| 56 | NEK1 | 0.98124267 |
| 57 | CAMK2A | 0.96409676 |
| 58 | CSNK1G3 | 0.95867082 |
| 59 | LATS1 | 0.94310642 |
| 60 | MARK2 | 0.93595093 |
| 61 | LATS2 | 0.92924621 |
| 62 | FGR | 0.92773589 |
| 63 | NUAK1 | 0.90841035 |
| 64 | TRPM7 | 0.90731318 |
| 65 | CAMK1G | 0.89711350 |
| 66 | EPHA2 | 0.89464466 |
| 67 | MAPK15 | 0.88667320 |
| 68 | TRIM28 | 0.87948824 |
| 69 | PAK6 | 0.87613141 |
| 70 | MAP2K7 | 0.87392483 |
| 71 | PRKD3 | 0.86896668 |
| 72 | MUSK | 0.86232512 |
| 73 | SGK2 | 0.84830704 |
| 74 | MAP3K4 | 0.84599887 |
| 75 | CSNK1G1 | 0.80504827 |
| 76 | TGFBR1 | 0.79805904 |
| 77 | PRKD1 | 0.79089681 |
| 78 | CDK5 | 0.78201489 |
| 79 | ROCK1 | 0.78162517 |
| 80 | PAK2 | 0.75877536 |
| 81 | BMPR2 | 0.74434494 |
| 82 | EPHA4 | 0.73702566 |
| 83 | NTRK2 | 0.73551315 |
| 84 | MAPK12 | 0.70243659 |
| 85 | PRKCH | 0.67972027 |
| 86 | OBSCN | 0.67656138 |
| 87 | STK38 | 0.66534660 |
| 88 | LMTK2 | 0.66525229 |
| 89 | GRK7 | 0.65333850 |
| 90 | ZAK | 0.65275477 |
| 91 | CDK14 | 0.64463209 |
| 92 | MAP3K9 | 0.63639761 |
| 93 | PRKCG | 0.63613074 |
| 94 | SRPK1 | 0.61256232 |
| 95 | RIPK1 | 0.58999068 |
| 96 | PRKG1 | 0.58882173 |
| 97 | TTK | 0.58184967 |
| 98 | FGFR1 | 0.58036886 |
| 99 | WEE1 | 0.56979704 |
| 100 | EPHA3 | 0.56509717 |
| 101 | TESK1 | 0.56464669 |
| 102 | CAMK2G | 0.56128438 |
| 103 | GSK3A | 0.55586158 |
| 104 | PDK2 | 0.55064606 |
| 105 | GRK5 | 0.54034274 |
| 106 | SGK1 | 0.53146321 |
| 107 | KSR1 | 0.52743843 |
| 108 | ADRBK1 | 0.51956632 |
| 109 | DYRK1A | 0.51353898 |
| 110 | MKNK2 | 0.50764110 |
| 111 | STK3 | 0.50257616 |
| 112 | PTK2 | 0.50145583 |
| 113 | PLK3 | 0.48560989 |
| 114 | YES1 | 0.48378554 |
| 115 | MYLK | 0.48364062 |
| 116 | PDGFRB | 0.46135933 |
| 117 | MAPK7 | 0.45470803 |
| 118 | CDK18 | 0.45080801 |
| 119 | CAMK1D | 0.44833700 |
| 120 | WNK3 | 0.44776532 |
| 121 | TTN | 0.43894218 |
| 122 | GRK1 | 0.43375133 |
| 123 | INSR | 0.43136309 |
| 124 | MOS | 0.42345337 |
| 125 | MST1R | 0.42094007 |
| 126 | CSNK1D | 0.41655841 |
| 127 | PRKCQ | 0.40153590 |
| 128 | CDK15 | 0.39483887 |
| 129 | TGFBR2 | 0.39213580 |
| 130 | ERBB4 | 0.39013061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.12632972 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.42310411 |
| 3 | Axon guidance_Homo sapiens_hsa04360 | 2.04768319 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95512001 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.77750996 |
| 6 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.75399111 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.72062193 |
| 8 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64944036 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54306090 |
| 10 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.51620888 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.51220497 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48248198 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.47024347 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.44675827 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.44139979 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41352314 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.35584722 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.33502985 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.32609724 |
| 20 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27513989 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.27023895 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.26862782 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26854013 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.25782163 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24385598 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.23786690 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22117055 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21711893 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.19505510 |
| 30 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.18063028 |
| 31 | Tight junction_Homo sapiens_hsa04530 | 1.16734651 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.16657444 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.16211709 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.14474204 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14171358 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13155710 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09645108 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09210518 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08680359 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.08061857 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07362405 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07335469 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06438034 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04894065 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04781997 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.03808732 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03326746 |
| 48 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.02950003 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.02901738 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.00474277 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 0.99823065 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99108797 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98762530 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98725018 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98710247 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98171606 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97920581 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.97767076 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96157113 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 0.96149636 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95599560 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.95284321 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.94514355 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94433684 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94049193 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93786436 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92736104 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.92388843 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92343901 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92282564 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90495104 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89640569 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89214598 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89121998 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.88255445 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85600179 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85313066 |
| 78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83709559 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83684268 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.82596381 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81891562 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81748733 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81216431 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81143715 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79897775 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.78983859 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77585095 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76790084 |
| 89 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76319223 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75887036 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75491202 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75477125 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74948033 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73481043 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73006440 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72800633 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.72706943 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72677624 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72315520 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72131446 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71814524 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71413093 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71407714 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70996277 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70622133 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70581463 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.69405516 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68373159 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.68323325 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68193813 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67950951 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67585388 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66579448 |
| 114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66426369 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.65849558 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64526846 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.64336677 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63136719 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.63004707 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62790186 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62734078 |
| 122 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62691543 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.62581712 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62166502 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60808632 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.60595924 |
| 127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59272914 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59006216 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58546469 |
| 130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58446386 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.58152318 |
| 132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57914682 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53553804 |
| 134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50846946 |
| 135 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49488337 |
| 136 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48752477 |

